Federal Register
Notice: FDA is withdrawing approval of 65 NDAs and 52 ANDAs from multiple applicants. The holders of the applications notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn. To view this notice, click here.